Health Affairs April 6, 2020
Basit Chaudhry, Lisa Tran

There have been a number of unprecedented regulatory flexibilities issued by the Centers for Medicare and Medicaid Services (CMS) in recent weeks given the COVID-19 pandemic, done with the intention of easing the burdens on the health care system to be more responsive to our patients’ needs. But one issue that has been left in limbo is the status of a number of value-based programs at CMS and its Center for Medicare and Medicaid Innovation (the Innovation Center). Where possible by regulatory action, the Department of Health and Human Services should suspend all down-side risk mechanisms in alternative payment models given the current mass scale disruption of the US health care system caused by the novel coronavirus.

There are three...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: ACO (Accountable Care), CMS, Govt Agencies, Health System / Hospital, Insurance, MACRA, Medicare, Patient / Consumer, Payment Models, Physician, Primary care, Provider, Value Based
Humana looks to deepen meaning of 'value-based care'
The Dark Side of AI in Medicare Advantage: When Value-Based Payment Eclipses Value-Based Care
Outpatient Mental Health Navigates Greater Value-Based Care, Quality Tracking From Payers
The next wave: 2025 trends set to transform value-based care
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP

Share This Article